An accomplished and purpose-driven leader, Will Downie is Argenta’s Chief Executive Officer (CEO). With a passion for building high-performing teams and creating collaborative cultures, Will has a strong track record in helping companies to successfully transform their businesses in both publicly listed and private equity settings. Although the CEO role at Argenta is Will’s first role in animal health, he has been the loving owner of many pets over the years and currently has a Cockapoo dog and Bengal and Siamese cats in his family.
Will has a long-standing career in the healthcare industry and an extensive understanding of the drug development and manufacturing market. Prior to joining Argenta in April 2022, Will was the CEO of Vectura, a leading global CDMO for inhaled drug development solutions. In this role, he transformed the company into a global leader in its space, almost doubling the valuation. Prior to this, he was the Chief Commercial Officer at Catalent Inc. for 10 years, and earlier in his career worked in a range of senior sales and marketing positions at GE Healthcare, Sanofi and Merck.
Will holds a BSc (Hons) in biochemistry from the University of Edinburgh, UK.
